[1] Frazzoni L, La Marca M, Guido A, et al.Pelvic radiation disease:Updates on treatment options[J].World J Clin Oncol, 2015, 6(6):272-280.DOI:10.5306/wjco.v6.i6.272.
[2] Morris Al, Haboubi Y.Pelvic radiation therapy:Between delight and disaster[J].World J Gastrointest Surg, 2015, 7(11):279-288.DOI:10.4240/wjgs.v7.i11.279.
[3] Benderitter M, Gourmelon P, Bey E, et al.New emerging concepts in the medical management of local radiation injury[J].Health Phys, 2010, 98(6):851-857.DOI:10.1097/HP.0b013e-3181c9f79a.
[4] Armes J, Crowe M, Colbourne L, et al.Patients' supportive care needs beyond the end of cancer treatment:a prospective, longitudinal survey[J].J Clin Oncol, 2009, 27(36):6172-6179.DOI:10.1200/JCO.2009.22.5151.
[5] Andreyev HJ, Wotherspoon A, Denham W, et al.Defining pelvic-radiation disease for the survivorship era[J].Lancet Oncol, 2010, 11(4):310-312.DOI:10.1016/S1470-2045(10)70026-7.
[6] Denham W, Hauer-Jensen M.Radiation induced bowel injury:a neglected problem[J].Lancet, 2013, 382(9910):2046-2047.DOI:10.1016/S0140-6736(13)61946-7.
[7] Fuccio L, Frazzoni L, Guido A.Prevention of pelvic radiation disease[J].World J Gastrointest Pharmacol Ther, 2015, 6(1):1-9.DOI:10.4292/wjgpt.v6.i1.1.
[8] Brenn T, Fletcher D.Postradiation vascular proliferations:an increasing problem[J].Histopathology, 2006, 48(1):106-114.DOI:10.1111/j.1365-2559.2005.02293.x.
[9] Andreyev J.Pelvic radiation disease[J].Colorectal Dis, 2015, 17(1):2-6.DOI:10.1111/codi.12812.
[10] Hauer-Jensen M, Denham W, Andreyev J.Radiation enteropathy——pathogenesis, treatment and prevention[J].Nat Rev Gastroenterol Hepatol, 2014, 11(8):470-479.DOI:10.1038/nrgastro.2014.46.
[11] 李幼生.从放射性盆腔病概念的产生看疾病整体治疗的重要性[J].医学研究生学报, 2016, 29(5):449-452.DOI:10.16571/j.cnki.1008-8199.2016.05.001.
Li YS.Radaition pelvicopathy:a comprehensive and interdiscipli-nary approach[J].J Med Postgraduates, 2016, 29(5):449-452.  doi: 10.16571/j.cnki.1008-8199.2016.05.001
[12] Teo T, Sebag-Montefiore D, Donnellan F.Prevention and management of radiation-induced late gastrointestinal toxicity[J].Clin Oncol(R Coll Radiol), 2015, 27(11):656-667.DOI:10.1016/j.clon.2015.06.010.
[13] Laterza L, Cecinato P, Guido A, et al.Management of radiation-induced rectal bleeding[J].Curr Gastroenterol Rep, 2013, 15(11):355.DOI:10.1007/s11894-013-0355-z.
[14] 沈亚丽, 李霞, 赵娅琴, 等.宫颈癌术后放射治疗容积旋转调强与静态调强、三维适形计划的剂量学研究[J].华西医学, 2015, 30(6):1096-1100.
Shen YL, Li X, Zhao YQ, et al.Dosimetric comparison among volumetric-modulated arc therapy, intensity modulated radiotherapy and three-dimensional conformal radiotherapy as adjuvant radiotherapy for cervical cancer[J].West Chin Med J, 2015, 30(6):1096-1100.
[15] Shadad K, Sullivan J, Martin D, et al.Gastrointestinal radiation injury:prevention and treatment[J].World J Gastroenterol, 2013, 19(2):199-208.DOI:10.3748/wjg.v19.i2.199.
[16] 戴丹丹, 刘孟娟, 叶晓春.氨磷汀的临床应用概况[J].海峡药学, 2014, 26(5):79-80.
Dai DD, Liu MJ, Ye XC.The clinical application of amifostine[J].Strait Pharm J, 2014, 26(5):79-80.
[17] Katsanos KH, Briasoulis E, Tsekeris P, et al.Randomized phase II exploratory study of prophylactic amifostine in cancer patients who receive radical radiotherapy to the pelvis[J].J Exp Clin Cancer Res, 2010, 29:68.DOI:10.1186/1756-9966-29-68.
[18] Koukourakis MI, Kyrgias G, Panteliadou M, et al.Dose escalation of amifostine for radioprotection during pelvic accelerated radiotherapy[J].Am J Clin Oncol, 2013, 36(4):338-343.DOI:10.1097/COC.0b013e318248d882.
[19] KiliçD, Egehan I, Ozenirler S, et al.Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of sulphasalazine in preventing acute gastrointestinal complications due to radiotherapy[J].Radiother Oncol, 2000, 57(2):125-129.DOI:10.1016/S0167-8140(00)00254-1.
[20] Pal S, Adhikary SS, Bhattacharya B, et al.A prospective randomized controlled trial to study the role of sulfasalazine in prevention of acute gastrointestinal toxicity associated with concurrent chemoradiation in carcinoma cervix[J].Clin Cancer Investig J, 2013, 2:118-121.DOI:10.4103/2278-0513.113633.
[21] Gibson RJ, Keefe DM, Lalla RV, et al.Systematic review of agents for the management of gastrointestinal mucositis in cancer patients[J].Support Care Cancer, 2013, 21(1):313-326.DOI:10.1007/s00520-012-1644-z.
[22] Jahraus CD, Bettenhausen D, Malik U, et al.Prevention of acute radiation-induced proctosigmoiditis by balsalazide:a randomized, double-blind, placebo controlled trial in prostate cancer patients[J].Int J Radiat Oncol Biol Phys, 2005, 63(5):1483-1487.DOI:10.1016/j.ijrobp.2005.04.032.
[23] 王锦, 高青.二丙酸倍氯米松和传统糖皮质激素灌肠治疗溃疡性结肠炎:Meta分析[J].胃肠病学和肝病学杂志, 2014, 23(7):774-778.DOI:10.3969/j.issn.1006-5709.2014.07.015.
Wang J, Gao Q.Beclomethasone dipropionate versus traditional glucocorticosteroids enema in the treatment of ulcerative colitis:a Meta-analysis[J].Chin J Gastroenterol Hepatol, 2014, 23(7):774-778.  doi: 10.3969/j.issn.1006-5709.2014.07.015
[24] Fuccio L, Guido A, Laterza L, et al.Randomised clinical trial:preventive treatment with topical rectal beclomethasone dipropionate reduces post-radiation risk of bleeding in patients irradiated for prostate cancer[J].Aliment Pharmacol Ther, 2011, 34(6):628-637.DOI:10.1111/j.1365-2036.2011.04780.x.
[25] Khan AM, Birk JW, Anderson JC, et al.A prospective randomized placebo-controlled double-blinded pilot study of misoprostol rectal suppositories in the prevention of acute and chronic radiation proctitis symptoms in prostate cancer patients[J].Am J Gastroenterol, 2000, 95(8):1961-1966.DOI:10.1111/j.1572-0241.2000.02260.x.
[26] Hille A, Schmidberger H, Hermann RM, et al.A phase III randomized, placebo-controlled, double-blind study of misoprostol rectal suppositories to prevent acute radiation proctitis in patients with prostate cancer[J].Int J Radiat Oncol Biol Phys, 2005, 63(5):1488-1493.DOI:10.1016/j.ijrobp.2005.05.063.
[27] O'brien PC, Franklin CI, Dear KB, et al.A phase III double-blind randomised study of rectal sucralfate suspension in the prevention of acute radiation proctitis[J].Radiother Oncol, 1997, 45(2):117-123.DOI:10.1016/S0167-8140(97)00146-1.
[28] Hovdenak N, Sørbye H, Dahl O.Sucralfate does not ameliorate acute radiation proctitis:randomised study and meta-analysis[J].Clin Oncol(R Coll Radiol), 2005, 17(6):485-491.DOI:10.1016/j.clon.2005.04.011.
[29] Kneebone A, Mameghan H, Bolin T, et al.Effect of oral sucralfate on late rectal injury associated with radiotherapy for prostate cancer:A double-blind, randomized trial[J].Int J Radiat Oncol Biol Phys, 2004, 60(4):1088-1097.DOI:10.1016/j.ijrobp.2004.04.033.
[30] Reiff C, Kelly D.Inflammatory bowel disease, gut bacteria and probiotic therapy[J].Int J Med Microbiol, 2010, 300(1):25-33.DOI:10.1016/j.ijmm.2009.08.004.
[31] Fuccio L, Guido A, Eusebi LH, et al.Effects of probiotics for the prevention and treatment of radiation-induced diarrhea[J].J Clin Gastroenterol, 2009, 43(6):506-513.DOI:10.1097/MCG.0b013e3181a1f59c.
[32]

Fuccio L, Guido A, Andreyev HJ.Management of intestinal complications in patients with pelvic radiation disease[J/OL].Clin Gastroenterol Hepatol, 2012, 10(12):1326-1334.e4[2016-10-20].https://www.ncbi.nlm.nih.gov/pubmed/22858731.DOI:10.1016/j.cgh.2012.07.017.